Victrex (LON:VCT)‘s stock had its “hold” rating reissued by analysts at Deutsche Bank in a report issued on Thursday. They presently have a GBX 2,200 ($29.42) target price on the stock. Deutsche Bank’s target price would indicate a potential downside of 16.48% from the stock’s current price.
Other equities research analysts have also issued reports about the company. Berenberg Bank upgraded Victrex to a “buy” rating and increased their price target for the stock from GBX 2,000 ($26.74) to GBX 2,600 ($34.76) in a research report on Wednesday, September 6th. Liberum Capital increased their price objective on Victrex from GBX 2,440 ($32.62) to GBX 2,770 ($37.04) and gave the company a “buy” rating in a research report on Monday, December 11th. Barclays decreased their price objective on Victrex from GBX 2,350 ($31.42) to GBX 2,270 ($30.35) and set an “equal weight” rating on the stock in a research report on Tuesday, November 28th. Peel Hunt lowered Victrex to a “hold” rating and set a GBX 2,300 ($30.75) price objective on the stock. in a research report on Tuesday, October 31st. Finally, JPMorgan Chase & Co. increased their price objective on Victrex from GBX 2,150 ($28.75) to GBX 2,250 ($30.08) and gave the company a “neutral” rating in a research report on Wednesday, December 6th. Eight equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of GBX 2,276.80 ($30.44).
Shares of Victrex (VCT) opened at GBX 2,634 ($35.22) on Thursday. The company has a market capitalization of $2,270.00 and a P/E ratio of 2,270.69. Victrex has a 12-month low of GBX 1,826 ($24.42) and a 12-month high of GBX 2,674 ($35.75).
In other Victrex news, insider Martin Court sold 441 shares of the stock in a transaction on Friday, December 15th. The stock was sold at an average price of GBX 2,618 ($35.00), for a total value of £11,545.38 ($15,437.06). Insiders acquired a total of 15 shares of company stock worth $37,550 over the last quarter.
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.